Definitive Healthcare Corp. Class A (DH) Dividend History

Company News

• Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

  Definitive Healthcare announced that it granted inducement awards, including 364,432 time-based restricted stock units, to its new SVP of Growth and Sales Operations, Jeff Moyer, as part of his employment agreement.

  GlobeNewswire Inc.
• INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors

  Law Offices of Howard G. Smith is investigating Definitive Healthcare Corp. (DH) for possible violations of federal securities laws after the company disclosed a $363.6 million goodwill impairment and reduced its fiscal year 2024 guidance, causing a significant drop in its stock price.

  Benzinga
• The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors

  The Law Offices of Frank R. Cruz announced an investigation into Definitive Healthcare Corp. after the company disclosed a $363.6 million goodwill impairment and reduced its 2024 fiscal year guidance, causing a 32.1% drop in its stock price.

  Benzinga
• United Kingdom Healthcare Market Report 2024: The Role of Private Payers and Independent Sector Providers, Alongside the Public Sector, in the Funding and Delivery of UK Health and Care Services

  The report provides a comprehensive overview of the UK independent healthcare and social care sectors, including data on market value, capacity, trends, leading players, funding sources, and key issues. It highlights the role of private payers and independent sector providers, alongside the public sector, in the funding and delivery of UK health and care services.

  GlobeNewswire Inc.

  Featured Companies: ADUS AHS CVS PSP
• Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare’s Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

  GlobeNewswire Inc.